Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Hina Takano"'
Autor:
Erina Hosoya, Jun Ando, Shintaro Kinoshita, Yoshiki Furukawa, Yuko Toyoshima, Yoko Azusawa, Toru Mitsumori, Eriko Sato, Hina Takano, Yutaka Tsukune, Naoki Watanabe, Tomoiku Takaku, Hajime Yasuda, Yasuharu Hamano, Makoto Sasaki, Shuko Nojiri, Midori Ishii, Miki Ando
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/e8779e76f6e044c0b3459e7702ac7507
Autor:
Kyohei Misawa, Hajime Yasuda, Daisuke Koyama, Tadaaki Inano, Akemi Inoguchi, Chinami Shirasu, Hina Takano, Noriaki Iwao, Miki Ando, Michiaki Koike
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 992-995 (2022)
Abstract Paroxysmal cold hemoglobinuria (PCH) is an extremely rare subtype of autoimmune hemolytic anemia (AIHA) in adults. PCH is caused by the biphasic Donath–Landsteiner (DL) antibody which fixes complement to red blood cells at low temperatures
Externí odkaz:
https://doaj.org/article/165e557539f44db29146297933150b14
Autor:
Kyohei, Misawa, Hajime, Yasuda, Hironari, Matsuda, Munechika, Hara, Tomonori, Ochiai, Daisuke, Koyama, Hina, Takano, Noriaki, Iwao, Michiaki, Koike
Publikováno v:
Internal Medicine. 61:3421-3424
Immune checkpoint inhibitors (ICIs) are widely used for the treatment of various cancers. However, paradoxical exacerbation of neoplasms, referred to as "hyperprogressive disease," has been reported in a proportion of patients treated with anti-progr
Autor:
Hina Takano, Kensuke Narukawa, Yuma Noguchi, Tomoko Yamashita, Gaku Oshikawa, Akihiko Nishijima
Publikováno v:
Clinical Case Reports
Key Clinical Message The de novo myeloid sarcoma (MS) type of acute promyelocytic leukemia (APL) is rare, and clinical features may differ from extramedullary diseases in advanced APL. Many cases occur as a spinal tumor, and some occur in the absence
Autor:
Junichi Mukae, Takuya Komeno, Noriko Doki, Keisuke Tanaka, Atsushi Shinagawa, Takeshi Kobayashi, Kazuteru Ohashi, Takashi Kumagai, Megumi Akiyama, Naoki Wakimoto, Hiroshi Kojima, Daisuke Kudo, Shigeo Toyota, Yuichi Nakamura, Koh Yamamoto, Kazuhiko Kakihana, Tatsuya Saito, Hina Takano, Mitsuo Hori, Yuho Najima, Chikashi Yoshida, Masahide Yamamoto, Ikuyo Tsutsumi, Yasushi Okoshi, Takayuki Fujio, Aiko Igarashi
Publikováno v:
Acta Haematologica. 141:111-118
We assessed the efficacy and safety of weekly cyclophosphamide-bortezomib-dexamethasone (CBD) induction prior to autologous stem cell transplantation (ASCT) in newly diagnosed Japanese patients with multiple myeloma (MM). This regimen consisted of fo
Autor:
Tadashi Murase, Kaichi Nishiwaki, Hisashi Sakamaki, Naoki Takezako, Kosei Matsue, Junichi Sakamoto, Chiaki Nakaseko, Satoshi Morita, Kazuteru Ohashi, Yasuji Kouzai, Hina Takano, Takashi Kumagai, Hisashi Wakita, Shimousa Hematology Study Groups Kanto Cml, Chikashi Yoshida, Koiti Inokuchi
Publikováno v:
Cancer Science
This study presents the final report of the multicenter, prospective tyrosine kinase inhibitor discontinuation study, D‐STOP, after a 3‐year follow‐up of 54 patients with chronic CML who discontinued dasatinib after a sustained deep molecular r
Autor:
Junichi Sakamoto, Noriyoshi Iriyama, Satoshi Hashino, Satoshi Morita, Kazuteru Ohashi, Hina Takano, Shinya Kimura, Hisashi Sakamaki, Koiti Inokuchi, Chiaki Nakaseko, Masayuki Hino, Michihiro Uchiyama
Publikováno v:
Internal Medicine
Objective The aim of this study was to prospectively investigate the efficacy and safety profiles of low-dose dasatinib therapy (50 mg once daily). Methods Patients with chronic myeloid leukemia in the chronic phase (CML-CP) who were being treated wi
Autor:
Kosei Matsue, Chikashi Yoshida, Kaichi Nishiwaki, Naoki Takezako, Hisashi Sakamaki, Tadashi Murase, Takashi Kumagai, Satoshi Morita, Kazuteru Ohashi, Yasuji Kouzai, Shimousa Hematology Study Groups, Hisashi Wakita, Koiti Inokuchi, Hina Takano, Chiaki Nakaseko, Junichi Sakamoto
Publikováno v:
Cancer Science
Tyrosine kinase inhibitors (TKIs) improve the prognosis of patients with chronic myelogenous leukemia (CML) by inducing substantial deep molecular responses (DMRs); some patients could successfully discontinue TKI therapy after maintaining DMR for
Publikováno v:
Clinical Case Reports
Key Clinical Message Myelolipoma is one of the rare causes of posterior mediastinal tumor. Surgical excision is effective, which differs from the treatment of extramedullary disease usually concomitant with myelodysplastic syndrome. Cytogenetic analy
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 60(10)
A 70-year-old man was admitted to our hospital due to fever, lymphadenopathy, and leukocytosis. White blood cell count was 22,700/µl with 92% blastoid cells. Bone marrow examination revealed abnormal lymphoid cell expansion. Abnormal cells expressed